Original Query: ALL
Previous Study | Return to List | Next Study

Impact of Nilotinib on Safety, Biomarkers and Clinical Outcomes in Mild to Moderate Alzheimer's Disease (AD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02947893
Recruitment Status : Recruiting
First Posted : October 28, 2016
Last Update Posted : February 20, 2018
Information provided by (Responsible Party):
R. Scott Turner, Georgetown University